Case Summary:

“[Client’s] development of nanoparticles for drug delivery has established methods that more effectively dispense drugs to patients. Consequently, his work is essential to combatting diseases such as cancer and mitigating their impact on healthcare and economic systems around the world.”

“[Client’s] work aligns with the priorities set forth by the FDA. He has safely and effectively prepared pharmaceutical particles for drug delivery while constructing a reusable platform to design and develop more expansive drugs to treat disease. As such, his work clearly bolsters the U.S. pharmaceutical industry, which accounts for over $1.3 trillion in economic output, while supporting safer and more specialized drug delivery.”

“[The client] is a prolific drug delivery researcher working precisely in this domain. He has developed nanoparticles for drug delivery in the treatment of cancer, Alzheimer’s disease, and diabetes. As such, [client’s] work helps mitigate the impact of these diseases and directly promotes the healthcare interests of the United States.”

We at North America Immigration Law Group have had the opportunity to deal with thousands of clients over the years, and one thing that we have realized is that letters of recommendation need to be an essential part of every petition packet. We have noted that the support of peers from the scientific community helps solidify the claim of any individual petitioner. Thus, when our NIW (National Interest Waiver) client from Syria obtained his 4 letters of recommendation, we became even more certain of his case approval.

He is an assistant professor in the field of drug delivery with a Ph.D. in pharmaceutical science. As an expert in the field, he had been working on the development of new pediatric drugs that mask unpleasant tastes and the development of new drug delivery carriers based on nanotechnology with a one-step reproducible process in order to develop DNA and RNA vaccines and treat cancer and other diseases.

It was evident that his research was of great importance because it advanced pediatric drugs by masking unpleasant tastes and easing the process of ingestion. At the same time, he has completed at least 21 reviews to date. His research has resulted in 47 peer-reviewed journal articles (8 of them first-authored and 21 of them as a corresponding author), 1 book, and 1 book chapter. At the same time, these publications have been cited a total of 270 times according to Google Scholar. We also found evidence of his major funding sources such as the Malaysian Ministry of Higher Education, and the Malaysian Ministry of Science, Technology, and Innovation.

So, when he received his approval only 2 months and 5 days after filing, we were happy to have been a part of his success story. We wish him the very best in all future endeavors.